Literature DB >> 22903333

Chylous ascites complicating elective abdominal aortic aneurysm repair: case report and review of treatment options.

Hashem M Barakat1, Yousef Shahin, Peter McCollum.   

Abstract

INTRODUCTION: Chylous ascitis is a rare complication of abdominal aortic aneurysm (AAA) surgery with only 38 cases reported since the early 70s. Due to their anatomical relation with the abdominal aorta, cisterna chyli injury is more common following open AAA repairs when compared to other surgeries; 81% of all postsurgical chylous ascites reported. CASE
PRESENTATION: We present a case of severe chylous ascitis following elective AAA repair in a 76-year-old caucasian male who gradually developed abdominal distension following discharge. A conservative approach was followed by a peritoneovenous shunt insertion, but this had no clinical benefit. The site of chyle leak was identified and ligated at relaparatomy to eventually resolve his ascitis.
CONCLUSION: Many reports in literature demonstrate successful conservative measures and highlight the importance of nutritional status in the course of persistent postoperative chylous ascitis. In our experience, complete resolution only came after relaparatomy and repair of leaking lymphatics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903333     DOI: 10.1177/1538574412457083

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Chylous Ascites after Abdominal Aortic Aneurysm Repair.

Authors:  Shinichi Ohki; Soki Kurumisawa; Yoshio Misawa
Journal:  Ann Vasc Dis       Date:  2015-12-03

2.  Chylous Ascites Developing after Open Thoracoabdominal Aortic Aneurysm Repair in a Patient with Marfan Syndrome.

Authors:  Hakan Kara
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01

3.  Using aneurysm clips for repair of cisterna chyli injury during posterior spinal fusion.

Authors:  Robert McCabe; Doris Tong; Connor Hanson; Dejan Slavnic; Teck Mun Soo
Journal:  Surg Neurol Int       Date:  2021-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.